Benjamin Burnett
Stock Analyst at Stifel
(1.97)
# 1,611
Out of 4,412 analysts
51
Total ratings
38.89%
Success rate
-7.68%
Average return
Main Sectors:
Top Industries:
17 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IRON Disc Medicine | Maintains: Buy | $71 → $73 | $27.55 | +164.97% | 5 | Apr 8, 2024 | |
| ATRA Atara Biotherapeutics | Maintains: Hold | $4.8 → $2.3 | $0.69 | +233.33% | 2 | Apr 1, 2024 | |
| ACLX Arcellx | Reiterates: Buy | $82 | $51.92 | +57.94% | 3 | Mar 14, 2024 | |
| RPTX Repare Therapeutics | Maintains: Buy | $16 → $17 | $3.20 | +431.25% | 4 | Sep 25, 2023 | |
| RVMD Revolution Medicines | Maintains: Buy | $37 → $47 | $35.96 | +30.70% | 3 | Sep 21, 2023 | |
| IOVA Iovance Biotherapeutics | Reiterates: Buy | $25 | $11.64 | +114.78% | 9 | Sep 15, 2023 | |
| EFTR eFFECTOR Therapeutics | Upgrades: Buy | $33 → $175 | $1.89 | +9,159.26% | 4 | May 26, 2023 | |
| CRSP CRISPR Therapeutics AG | Maintains: Hold | $69 → $64 | $53.91 | +18.72% | 4 | May 9, 2023 | |
| ALLO Allogene Therapeutics | Maintains: Hold | $8 → $7.5 | $2.89 | +159.52% | 3 | May 4, 2023 | |
| FATE Fate Therapeutics | Maintains: Hold | $5.3 → $5 | $3.80 | +31.58% | 2 | May 4, 2023 | |
| IDYA IDEAYA Biosciences | Upgrades: Buy | $18 → $24 | $39.94 | -39.91% | 4 | Apr 24, 2023 | |
| DTIL Precision BioSciences | Maintains: Buy | $690 → $780 | $9.38 | +8,215.57% | 2 | Sep 10, 2021 | |
| NKTR Nektar Therapeutics | Upgrades: Buy | n/a | $1.32 | - | 2 | Jun 28, 2021 | |
| PGEN Precigen | Initiates: Buy | n/a | $1.41 | - | 1 | Feb 25, 2021 | |
| SGMO Sangamo Therapeutics | Initiates: Hold | n/a | $0.52 | - | 1 | Jan 6, 2021 | |
| BEAM Beam Therapeutics | Initiates: Hold | n/a | $21.38 | - | 1 | Jan 6, 2021 | |
| BLUE bluebird bio | Upgrades: Buy | n/a | $0.92 | - | 1 | Mar 27, 2020 |
Disc Medicine
Apr 8, 2024
Maintains: Buy
Price Target: $71 → $73
Current: $27.55
Upside: +164.97%
Atara Biotherapeutics
Apr 1, 2024
Maintains: Hold
Price Target: $4.8 → $2.3
Current: $0.69
Upside: +233.33%
Arcellx
Mar 14, 2024
Reiterates: Buy
Price Target: $82
Current: $51.92
Upside: +57.94%
Repare Therapeutics
Sep 25, 2023
Maintains: Buy
Price Target: $16 → $17
Current: $3.20
Upside: +431.25%
Revolution Medicines
Sep 21, 2023
Maintains: Buy
Price Target: $37 → $47
Current: $35.96
Upside: +30.70%
Iovance Biotherapeutics
Sep 15, 2023
Reiterates: Buy
Price Target: $25
Current: $11.64
Upside: +114.78%
eFFECTOR Therapeutics
May 26, 2023
Upgrades: Buy
Price Target: $33 → $175
Current: $1.89
Upside: +9,159.26%
CRISPR Therapeutics AG
May 9, 2023
Maintains: Hold
Price Target: $69 → $64
Current: $53.91
Upside: +18.72%
Allogene Therapeutics
May 4, 2023
Maintains: Hold
Price Target: $8 → $7.5
Current: $2.89
Upside: +159.52%
Fate Therapeutics
May 4, 2023
Maintains: Hold
Price Target: $5.3 → $5
Current: $3.80
Upside: +31.58%
IDEAYA Biosciences
Apr 24, 2023
Upgrades: Buy
Price Target: $18 → $24
Current: $39.94
Upside: -39.91%
Precision BioSciences
Sep 10, 2021
Maintains: Buy
Price Target: $690 → $780
Current: $9.38
Upside: +8,215.57%
Nektar Therapeutics
Jun 28, 2021
Upgrades: Buy
Price Target: n/a
Current: $1.32
Upside: -
Precigen
Feb 25, 2021
Initiates: Buy
Price Target: n/a
Current: $1.41
Upside: -
Sangamo Therapeutics
Jan 6, 2021
Initiates: Hold
Price Target: n/a
Current: $0.52
Upside: -
Beam Therapeutics
Jan 6, 2021
Initiates: Hold
Price Target: n/a
Current: $21.38
Upside: -
bluebird bio
Mar 27, 2020
Upgrades: Buy
Price Target: n/a
Current: $0.92
Upside: -